Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Actuate Therapeutics Inc | 10,049,996 | 10,049,996 | 0 | $61.51M | $27.54M | 52.09% | -$33.97M |
| Opus Genetics, Inc.(IRD) | 3,683,429 | 3,683,429 | 0 | $7.40M | $16.76M | 31.70% | +$9.36M |
| Cognition Therapeutics, Inc.(CGTX) | 6,000,000 | 6,000,000 | 0 | $8.10M | $4.56M | 8.63% | -$3.54M |
| Rein Therapeutics Inc.(RNTX) | 1,690,751 | 1,982,375 | +291,624 | $1.96M | $2.58M | 4.87% | +$615.8K |
| Lantern Pharma Inc.(LTRN) | 1,009,507 | 864,435 | -145,072 | $3.06M | $1.18M | 2.24% | -$1.87M |
| In8bio Inc | 253,417 | 167,805 | -85,612 | $593.0K | $248.4K | 0.47% | -$344.6K |